340B was never designed to be administered site-by-site, without regard for care delivery realities especially in infusion, where margins, workflows, and patient access are tightly linked
This is one of the reasons why they are also gaining popularity as a weight management tool
By completely dismissing compounded medications, experts may unintentionally bolster the black market and overlook the needs of patients who could benefit from these medications, contrary to the intentions of the exemption provided in federal law for compounding during a drug shortage
Even after a single use, the microscopic tip of the needle becomes dulled and jagged
SlimSEB promotes improved digestive comfort and additional weight loss for consumers who are already on GLP-1s and need support to stay there.* The Opportunity for Brands The GLP-1 consumer base isnt peaking, its compounding
Novo Nordisk has long dominated this market with its insulin and GLP-1 products, transforming the lives of patients globally with effective long-term management solutions
